Formerly called Depogen, however name is now used for another drug.

Recombiant human activated protein C.

A precursor of noradrenaline that is used in the treatment of parkinsonism. The racemic form (DL-threo-3, 4-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson's disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease. Administration of DL-threo-3, 4-dihydroxyphenylserine has been claimed to result in an improvement in this phenomenon but controlled studies have failed to demonstrate improvement. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

A hydroxyethylurea inhibitor.

A human antibody to death receptor 5.

Encoded on the leftwards strand of soybean nodule urate oxidase cDNA binds to a regulatory sequence in leghemoglobin c3 gene; GenBank X54365.